Advertisement
Screener

Immuneering Corporation (IMRX) Patents: Active

Immuneering Corporation Active Patents

3 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2022-07-08: Application 17791755; Invention MEK INHIBITORS AND THERAPEUTIC USES THEREOF; Applicant Immuneering Corporation; Status Patented Case.
  • 2021-05-19: Application 17324970; Invention SYSTEMS AND METHODS FOR RAPID GENE SET ENRICHMENT ANALYSIS; Applicant Immuneering Corporation; Status Patented Case.
  • 2019-02-01: Application 16265862; Invention SYSTEMS AND METHODS FOR RAPID GENE SET ENRICHMENT ANALYSIS; Applicant Immuneering Corporation; Status Patented Case.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2022-07-0817791755MEK INHIBITORS AND THERAPEUTIC USES THEREOFImmuneering CorporationPatented Case2025-07-0812351566US20230119327A1
Brett Matthew Hall
Bart Lieven Decorte
Peter John King
Ruben Leenders
Anita Wegert
Kevin Fowler
Sarah Kolitz
Robin Doodeman
Jarno Poelakker
Rutger Henk Adriaan Folmer
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
SCHMIDT, IZABELA MARIA
2021-05-1917324970SYSTEMS AND METHODS FOR RAPID GENE SET ENRICHMENT ANALYSISImmuneering CorporationPatented Case2024-03-2611942223
Grigoriy Koytiger
United States
RUDY, ANDREW J
2019-02-0116265862SYSTEMS AND METHODS FOR RAPID GENE SET ENRICHMENT ANALYSISImmuneering CorporationPatented Case2021-06-2211043305
Grigoriy Koytiger
United States
RUDY, ANDREW J

Similar stocks

Stock NameCountryMarket CapPE Ratio
Quantum Cyber N.V. (QUCY)$0.113B
BICYCLE THERAPEUTICS PLC (BCYC)$0.112B-1.56
GENELUX Corp (GNLX)United States$0.110B-3.83
Equillium, Inc. (EQ)United States$0.109B-11.27
OnKure Therapeutics, Inc. (OKUR)United States$0.119B-3.13
Biomea Fusion, Inc. (BMEA)United States$0.107B-3.30
Polaryx Therapeutics, Inc. (PLYX)United States$0.106B
Coya Therapeutics, Inc. (COYA)United States$0.121B-6.35
CUMBERLAND PHARMACEUTICALS INC (CPIX)United States$0.121B-8.95
Aardvark Therapeutics, Inc. (AARD)United States$0.121B-1.80